Vanda Pharmaceuticals (VNDA) News Today $6.18 +0.03 (+0.49%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 9:19 AM | prnewswire.comVanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024July 26 at 8:16 AM | marketbeat.comFY2024 EPS Estimates for Vanda Pharmaceuticals Inc. Lowered by Cantor Fitzgerald (NASDAQ:VNDA)Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) - Stock analysts at Cantor Fitzgerald reduced their FY2024 earnings per share estimates for Vanda Pharmaceuticals in a report issued on Wednesday, July 24th. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical company wJuly 26 at 4:39 AM | marketbeat.comVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Stock Position Raised by Sei Investments Co.Sei Investments Co. raised its position in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 39.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 518,851 shares of the biopharmaceutJuly 21, 2024 | marketbeat.comAcadian Asset Management LLC Purchases 107,203 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)Acadian Asset Management LLC lifted its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 4.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,370,335 shares of the biopharmaceutical cJuly 21, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)July 20, 2024 | marketbeat.comVanda Pharmaceuticals (NASDAQ:VNDA) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on shares of Vanda Pharmaceuticals in a report on Saturday. They issued a "hold" rating on the stock.July 15, 2024 | marketbeat.comSusquehanna Fundamental Investments LLC Takes Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)Susquehanna Fundamental Investments LLC purchased a new stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 281,683July 15, 2024 | marketbeat.comBrokers Issue Forecasts for Vanda Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:VNDA)Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for Vanda Pharmaceuticals in a report issued on Thursday, July 11th. Cantor Fitzgerald analyst C. Duncan anticipates that the biopharmaceutical company will earn ($0July 12, 2024 | marketbeat.comVanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by Analysts at StockNews.comStockNews.com started coverage on shares of Vanda Pharmaceuticals in a report on Friday. They set a "hold" rating on the stock.July 11, 2024 | marketbeat.comCantor Fitzgerald Begins Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)Cantor Fitzgerald started coverage on Vanda Pharmaceuticals in a research report on Thursday. They set an "overweight" rating and a $11.00 target price for the company.July 4, 2024 | marketbeat.comVanda Pharmaceuticals (NASDAQ:VNDA) Shares Pass Above 200-Day Moving Average of $4.57Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Cross Above Two Hundred Day Moving Average of $4.57July 1, 2024 | prnewswire.comFederal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and ApotexJune 26, 2024 | reuters.comFuture Pak withdraws offer to buy Vanda PharmaceuticalsJune 26, 2024 | businesswire.comFuture Pak Withdraws Proposal to Purchase Vanda Pharmaceuticals Inc.June 23, 2024 | marketbeat.comProfit Investment Management LLC Decreases Stock Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)Profit Investment Management LLC decreased its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 43.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 220,June 20, 2024 | benzinga.comVanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionJune 19, 2024 | reuters.comVanda rejects Future Pak and Cycle Pharma's takeover offersJune 19, 2024 | prnewswire.comVanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its ShareholdersJune 14, 2024 | marketbeat.comGSA Capital Partners LLP Boosts Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)GSA Capital Partners LLP lifted its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 39.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 567,756 shares of the biopharmaceutJune 13, 2024 | globenewswire.comGlobal Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%June 13, 2024 | prnewswire.comVanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future PakJune 13, 2024 | reuters.comFuture Pak raises cash portion of buyout offer for VandaJune 13, 2024 | businesswire.comFuture Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.June 10, 2024 | businesswire.comCIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and NeuromodulationJune 10, 2024 | businesswire.comGlancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.June 6, 2024 | prnewswire.comVanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.June 3, 2024 | marketbeat.comTrexquant Investment LP Sells 169,741 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)Trexquant Investment LP reduced its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 61.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 104,511 shaMay 31, 2024 | marketbeat.comShort Interest in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Rises By 21.7%Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 2,800,000 shares, an increase of 21.7% from the April 30th total of 2,300,000 shares. Currently, 5.1% of the shares of the stock are short sold. Based on an average trading volume of 2,350,000 shares, the days-to-cover ratio is presently 1.2 days.May 30, 2024 | prnewswire.comVanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare ConferenceMay 30, 2024 | prnewswire.comVanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®May 29, 2024 | prnewswire.comVanda Pharmaceuticals Announces Presentations at SLEEP 2024May 24, 2024 | marketwatch.comVanda Pharma Rejects Future Pak's Sweetened Takeover BidMay 24, 2024 | msn.comVanda Pharmaceuticals rejected sweetened bid from Future PakMay 24, 2024 | prnewswire.comVanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its ShareholdersMay 20, 2024 | marketbeat.comAssenagon Asset Management S.A. Cuts Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)Assenagon Asset Management S.A. lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 54.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 730,820 shares of the biopharmaceutical company's stock after sellinMay 15, 2024 | markets.businessinsider.comVanda Pharma Reports Positive Results From Second Phase III Study Of TradipitantMay 15, 2024 | msn.comVanda reports positive Phase 3 data for motion sickness drugMay 15, 2024 | prnewswire.comVanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion SicknessMay 10, 2024 | finance.yahoo.comVanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue EstimatesMay 9, 2024 | finance.yahoo.comVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finanznachrichten.deVanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comVanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 9, 2024 | finance.yahoo.comQ1 2024 Vanda Pharmaceuticals Inc Earnings CallMay 8, 2024 | msn.comVanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46MMay 8, 2024 | markets.businessinsider.comVNDA Stock Earnings: Vanda Pharma Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | prnewswire.comVanda Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | finanznachrichten.deVanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future PakMay 7, 2024 | markets.businessinsider.comVanda Pharma Receives Revised Unsolicited Takeover Proposal From Future PakMay 7, 2024 | msn.comVanda Pharmaceuticals up 15% as Future Pak sweetens bidMay 7, 2024 | prnewswire.comVanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak Get Vanda Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VNDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… VNDA Media Mentions By Week VNDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VNDA News Sentiment▼0.990.61▲Average Medical News Sentiment VNDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VNDA Articles This Week▼83▲VNDA Articles Average Week Get Vanda Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VNDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Gossamer Bio News Today AnaptysBio News Today Dynavax Technologies News Today Ironwood Pharmaceuticals News Today Innoviva News Today OPKO Health News Today Emergent BioSolutions News Today Lexicon Pharmaceuticals News Today Agenus News Today XOMA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VNDA) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VNDA Stock Alerts